Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
ESC Working Group on Cardiovascular Pharmacotherapycontact@escardio.orgDD/MM/YYYY
Pharmacology and Pharmacotherapy
Online event
Summary
This event will provide a deep insight into the long journey which brings pharmacological compounds from bench to bedside, i.e. from trial design for testing new drugs (generation of evidence and its critical appraisal) to implementation of pharmacological treatments for daily use in science and patient care.
Learning objectives
Reduction of cardiovascular disease burden by pharmacotherapy is a multistep approach, which requires:
the identification of new potential drugs;
testing new potential pharmacological compounds in a trial setting;
regulatory approval;
implementation of therapies in clinical practice.
The specific aim of the All About Clinical Trials course is to improve competency and confidence in:
Designing and planning successful clinical trials;
Evaluating and following the correct processes and regulatory procedures (GCP certificate included);
Effectively analysing and interpreting trial data through highly interactive workshops.
Conference scientific committee
Prof. Sven Wassmann, Germany
Prof. Gianluigi Savarese, Sweden
Scientific programme
This programme is subject to change.
Session 1. How to design and run a clinical trial
An overview of the different aspects of clinical trials
Planning and running a clinical trial: site perspective
Traditional versus novel trial designing
Session 2. Regulatory aspects
Requirements from regulatory agencies and post-marketing surveillance
Session 3. Registries and registry-based trials
Registry-based trials in ischemic heart disease
Registry-based trials in heart failure
Session 4. Issues in clinical trials
Challenges of running clinical trials in a pandemic
Since its launch in 2015, more than 350 participants have taken this course in clinical trials.
95% of participants would recommend the course to their peers
65% attend the course to learn about methodology for designing and running a clinical trial
54% attend the course to learn statistical approaches
Testimonial
“The course allowed me not only to gain a deeper insight into the complex process of organising clinical trials, but it also offered an opportunity to discuss specific methodological pitfalls and interpret the results in cooperation with professionals who represent the highest level of expertise in the field. I highly recommend the course both to experienced investigators and to young researchers, since apart from the conventional aspects of clinical trials methodology; it also presented a novel approach to run the research efficiently and successfully.” Aleksandra Gąsecka, Poland
Organised by
Address
European Society of Cardiology
European Heart House Les Templiers 2035 Route des Colles CS 80179 Biot
This programme is supported by Daiichi Sankyo and Novartis Pharma AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
This programme is supported by Daiichi Sankyo and Novartis Pharma AG in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease.